Zoetis Inc. announced that effective April 16, 2024, Heidi C. Chen will cease her role as Executive Vice President, General Counsel and Corporate Secretary, and Business Lead of Human Health Diagnostics of Zoetis Inc. Ms. Chen will continue as an employee advisor of the Company through July 16, 2024, after which time it is anticipated she will serve as a non-employee consultant. Roxanne Lagano, Executive Vice President, Chief Human Resources Officer and Global Operations, will serve as interim General Counsel and Corporate Secretary while the Company conducts a search for Ms. Chen?s permanent replacement.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
159.7 USD | +0.81% | +9.73% | -19.09% |
Apr. 29 | Zoetis to Sell Medicated-Feed-Additive Portfolio to Phibro for $350 Million | DJ |
Apr. 29 | Zoetis to Sell Medicated Feed Additives Business to Phibro Animal Health for $350 Million | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-19.09% | 72.97B | |
-8.93% | 6.69B | |
+21.38% | 3.6B | |
+2.20% | 1.44B | |
-16.99% | 1.34B | |
-7.81% | 1.25B | |
-26.05% | 1.24B | |
-12.71% | 1.15B | |
-4.03% | 1.01B | |
-23.05% | 817M |
- Stock Market
- Equities
- ZTS Stock
- News Zoetis Inc.
- Zoetis Inc. Announces Executive Changes